Dr. Luis E. Vazquez, MD, PhD

Dr. Vazquez practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Vazquez's NPI, 1083989719, was assigned on March 13, 2012. Dr. Vazquez graduated from Stanford University School Of Medicine in 2009. Dr. Vazquez holds Florida license ME116786.

Dr. Vazquez's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Vazquez's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Vazquez is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Vazquez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vazquez practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Vazquez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Vazquez is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Vazquez's licenses on file in 2 states: Florida and California.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, glaucoma, glaucoma surgery, secondary membranaous cataract surgery and vision problems among the conditions Dr. Vazquez treats.

CMS data shows 1,782 Medicare services from Dr. Vazquez across 9 procedure codes in 2024, for 545 Medicare patients. Medicare paid $78,707 for them.

CMS counts 545 Medicare patients who saw Dr. Vazquez in 2024. The largest group is 75 to 84, with 248 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vazquez's median patient age at 76, with 59% women.

In 2024, Dr. Vazquez wrote 10,805 Medicare Part D claims for 1,305 patients. 62% of them were for generic drugs. CMS names the drug for 10,720 of them, across 36 drugs with 11 or more claims each, at $706,838 in total drug cost. In 2023, CMS named 10,792 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Vazquez for performance year 2024, reported as part of a group. Dr. Vazquez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vazquez as offering telehealth. CMS counts 41 procedures of cataract surgery by Dr. Vazquez, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Vazquez, published from 2017 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Glaucoma, Retinal Ganglion Cells and Tomography, Optical Coherence. Dr. Vazquez has published most often in Ophthalmol Glaucoma. Dr. Vazquez's most frequent co-authors are Steven J. Gedde, MD, Elizabeth Ann Hodapp, MD and Richard K. Lee, MD, PhD.

Dmand AI links Dr. Vazquez to 1 clinical trial. Conditions studied include Glaucoma and Ocular Hypertension.

CMS Open Payments shows 39 general payments to Dr. Vazquez from 14 drug and device companies from 2016 to 2025. Grants make up the largest share, 86% of the total. Alcon Research Ltd paid the most, $50,000.

Dmand AI lists 1 award for Dr. Vazquez, most recently CMS Stage 1 EHR in 2014.

Dr. Vazquez graduated from Stanford University School Of Medicine in 2009.

Dr. Vazquez is in network with 12 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.